by NUR HAZIQAH A MALEK/ FILE PIX
Malaysia would stand to benefit in the personalised health index if there were greater inter-operability and systems to capture health-related data, which should be the key focus in the country and across the region.
Jeffrey Cheah School of Medicine and Health Sciences Professor Dr Maude Elvira Phipps said the country is currently undergoing the transition towards personalised healthcare.
“In that transition, there is enormous potential in improving existing health outcomes,” she said during the launch of the Asia-Pacific Personalised Health Index today.
She said that it is important to engage, encourage and motivate various stakeholders involved in the scenario of healthcare.
Personalised healthcare is also known as precision medicine, a medical model which separates people into different groups in which medical decisions, practices, interventions and products or treatments are tailored to the individual patient based on the predicted response and disease risk.
According to a report titled Personalised Medicine by FR Vogenberg in 2010, the model has the potential to tailor therapy with the best response as well as the highest safety margin to ensure better patient care.
In terms of the country’s performance towards the transition, Phipps said that Malaysia currently ranks seventh for data infrastructure for the transition, and has room for improvement for healthcare digitisation.
“Malaysia is also ranked third for good financial support for scale-ips, revealing that new personalised health technology companies should be able to find support developing solutions for the Malaysian market,” she said.